enVVeno Medical (NVNO) Misses Q3 EPS by 302c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts NVNO Hot Sheet
Join SI Premium – FREE
enVVeno Medical (NASDAQ: NVNO) reported Q3 EPS of ($6.29), $3.02 worse than the analyst estimate of ($3.27).
For earnings history and earnings-related data on enVVeno Medical (NVNO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Upgrades Lumentum (LITE) to Strong Buy, 'Overreaction to Marvell Offer'
- Active options: TSLA NVDA MU AMZN AAPL INTC SPCX AMD GOOGL META
- Estee Lauder (EL) PT Raised to $129 at Goldman Sachs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
